"Our results found that patients with G. lucidum extract in their anticancer regimen were 1.27 times more likely to respond to chemotherapy or radiotherapy than those without." https://t.co/1N9tUK7Bvs
Ganoderma lucidum (Reishi mushroom) for cancer treatment.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2019 – Oct 2025Where it's discussed
-
Facebook16 posts
-
News15 articles
-
X / Twitter14 posts
-
Blogs4 articles
-
Bluesky1 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions reveal a mixture of cautious acknowledgment and curiosity, with users referencing the systematic review and studies, such as one mentioning that G. lucidum may improve response to therapy, while others emphasize the inconclusive evidence for clinical benefits. The tone varies from skeptical to intrigued, reflecting ongoing debates about the mushroom's medicinal value.
Most posts acknowledge the limited evidence and express skepticism, reflecting partial agreement with the cautious conclusions of the publication.
Discussions show high interest, with users referencing specific studies, reviews, and clinical implications, indicating engagement with the topic.
Several comments analyze the research and mention their reactions to findings, like the mention of quality of life improvements, indicating moderate depth of engagement.
Posts highlight the significance of the systematic review's findings, with some referencing clinical relevance and cautionary notes about the treatment's efficacy.
Abstract in brief
- Ganoderma lucidum, also known as Reishi mushroom, is used in Asian medicine for its potential to boost the immune system and possibly fight cancer, but there is limited high-quality evidence.
- Researchers conducted a systematic review of five randomized controlled trials (RCTs), comparing G. lucidum with placebos or other treatments in cancer patients, to evaluate its effects on survival, tumor response, immune function, quality of life, and side effects.
- The current evidence is limited and does not provide conclusive proof that G. lucidum significantly benefits cancer treatment, highlighting the need for more rigorous clinical studies.
Top posts
Most liked on X and Bluesky@jorgegomezmarin @BluRadioCo @pcorrea78 Una Revisión Sistemática de la Cochrane concluye "Our review did not find sufficient evidence to justify the use of Ganoderma lucidum as a first-line treatment for cancer. It remains uncertain whether G. lucidum helps prolong long-term cancer survival." https://t.co/yyTn8GLJZk https://t.co/pW489FE2Tn
@mavr009 Bueno, una búsqueda rápida en PubMed arrojó algunos estudios con resultados positivos. Del que más me llamó la atención fue esta revisión Cochrane. https://t.co/z3sSnGrDlz https://t.co/9coKy8DtyB
Jin X, Ruiz Beguerie J, Sze D, Chan GCF. (Reishi mushroom) for cancer treatment. Cochrane Database of Systematic Reviews 2016, Issue 4. Art. No.: CD007731. DOI: 10.1002/14651858.CD007731.pub3
@ttitta @RealoveToday @JuanMAnayaC @rpocisv @claudiavaca5 The use of G. lucidum alone does not demonstrate significant clinical benefits in achieving a better tumour response." https://t.co/0NivNiCILZ https://t.co/X9q4jlzEPF
All mentions
Ganoderma Lucidum (Reishi) Mushroom Health Benefits and Risks
This video explores the properties of Reishi, also known as Ganoderma Lucidum, a medicinal mushroom used for centuries in traditional Chinese medicine. It discusses its immune-boosting, anti-inflammatory, and potential…
"Our results found that patients with G. lucidum extract in their anticancer regimen were 1.27 times more likely to respond to chemotherapy or radiotherapy than those without." https://t.co/1N9tUK7Bvs
En respuesta a #drmacias https://t.co/zFFatTUf05
@Johanaagg_ https://t.co/Ba7dDi9DKA
Ganoderma lucidum (Reishi mushroom) for cancer treatment - Jin, X - 2012 | Cochrane Library https://t.co/5ptvLjBZ8X
@mavr009 Bueno, una búsqueda rápida en PubMed arrojó algunos estudios con resultados positivos. Del que más me llamó la atención fue esta revisión Cochrane. https://t.co/z3sSnGrDlz https://t.co/9coKy8DtyB
"Four studies showed that patients in the G. lucidum group had relatively improved quality of life in comparison to controls." https://t.co/uEQ3ItPBrT
@ttitta @RealoveToday @JuanMAnayaC @rpocisv @claudiavaca5 The use of G. lucidum alone does not demonstrate significant clinical benefits in achieving a better tumour response." https://t.co/0NivNiCILZ https://t.co/X9q4jlzEPF
Despues de leer esto, nuestra flamante ministra de @MincienciasCo Mabel Torres. No quedo bien plantada https://t.co/Vd1SMtXycm
Jin X, Ruiz Beguerie J, Sze D, Chan GCF. (Reishi mushroom) for cancer treatment. Cochrane Database of Systematic Reviews 2016, Issue 4. Art. No.: CD007731. DOI: 10.1002/14651858.CD007731.pub3
@jaimerescuartas https://t.co/LLHV6FP5yZ
RT @DrAJRodriguezM: @jorgegomezmarin @BluRadioCo @pcorrea78 Una Revisión Sistemática de la Cochrane concluye "Our review did not find suffi…
@jorgegomezmarin @BluRadioCo @pcorrea78 Una Revisión Sistemática de la Cochrane concluye "Our review did not find sufficient evidence to justify the use of Ganoderma lucidum as a first-line treatment for cancer. It remains uncertain whether G. lucidum helps prolong long-term cancer survival." https://t.co/yyTn8GLJZk https://t.co/pW489FE2Tn
Ganoderma lucidum (Reishi mushroom) for cancer treatment https://t.co/cCzZU54dsK via @instapaper
LE
DH
KJ
JD
JR
FV
A
JT
DE
PR
JM
V